Martingale Asset Management L P Twist Bioscience Corp Transaction History

Martingale Asset Management L P

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$32.28 - $41.5 $55,037 - $70,757	-1,705 Reduced 9.64%	15,989 $548,000
Q4 2023 Feb 12, 2024	SELL	$15.08 - $38.61 $69,986 - $179,189	-4,641 Reduced 20.78%	17,694 $652,000
Q3 2023 Nov 14, 2023	SELL	$18.62 - $26.57 $48,374 - $69,028	-2,598 Reduced 10.42%	22,335 $452,000
Q2 2023 Aug 11, 2023	BUY	$11.49 - $20.46 $114,922 - $204,640	10,002 Added 66.99%	24,933 $510,000
Q1 2023 May 12, 2023	BUY	$14.6 - $30.9 $217,992 - $461,367	14,931 New	14,931 $225,000
Q1 2021 May 13, 2021	SELL	$105.48 - $207.97 $401,773 - $792,157	-3,809 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$76.64 - $167.89 $2.76 Million - $6.04 Million	-36,002 Reduced 90.43%	3,809 $538,000
Q3 2020 Nov 12, 2020	SELL	$45.46 - $78.79 $2.37 Million - $4.11 Million	-52,196 Reduced 56.73%	39,811 $3.02 Million
Q2 2020 Aug 10, 2020	BUY	$26.4 - $45.3 $1.25 Million - $2.15 Million	47,507 Added 106.76%	92,007 $4.17 Million
Q1 2020 May 11, 2020	BUY	$19.71 - $35.15 $877,095 - $1.56 Million	44,500 New	44,500 $1.36 Million

256

66.8M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.38B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.